In this work, authors present their goal-directed subgroup identification (GD-SI) framework, reconciling biological heterogeneity with clinical actionability, and offering a scalable infrastructure for precision trial design and personalized sepsis management.
- Zhongheng Zhang
- Lin Chen
- Leo Anthony Celi
